Studies related to Serum BDNF and Zinc

Zinc Monotherapy Increases Serum Brain-derived Neurotrophic Factor (BDNF) Levels And Decreases Depressive Symptoms In Overweight Or Obese Subjects: A Double-blind, Randomized, Placebo-controlled Trial

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 46
Sex Both Genders
Age Range 18-29, 30-44
Body Types Obese
Notes for this study:
Supplementation of zinc (30mg elemental) for 12 weeks in obese persons with depressive symptoms according to the BDI II rating scale was able to improve symptoms more than placebo; this improvement in depressive symptoms occurred alongside increases in serum BDNF concentrations.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.